Abstract
The totally subcutaneous implantable defibrillator (S-ICD, Boston Scientific, Natick, MA, USA) has recently been introduced as a new alternative to the conventional transvenous defibrillator system. The obvious advantages of this system are marketed as a minimization of lead complications and systemic infections. This innovative system can particularly be considered in young patients and special cohorts with anatomic variations. Inappropriate shock delivery has been
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
